Barclays has reiterated an Overweight rating on Envista Holdings Corporation but lowered its price target to $32 from $34. The dental products manufacturer is among top picks of Ariel Investments. Envista reported strong first-quarter results, with 9.5% core revenue growth translating into 25% adjusted EBITDA growth and 50% earnings-per-share growth. The company delivered growth across all major businesses, driven by customer engagement and new product commercialisation. For the full year, Envista maintained its guidance, expecting sales growth of 2% to 4% and adjusted EBITDA growth of 7% to 13%. The company projects adjusted diluted earnings per share between $1.35 and $1.45. Envista manages a portfolio of over 30 dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr. The company was spun off from Danaher Corporation.

The 100 most influential people in sports 2026: Mellody Hobson. June 9, 2026 By TIME Ariel Investments Co-CEO and Project Level Founder Mellody Hobson has been named to TIME's inaugural 100 Most Influential People in Sports list honoring the most prominent figures shaping the global sports landscape. In this interview, Mellody Hobson candidly discusses her opinions on the sports investing market and on private investments held by the Project Level Fund. These opinions are current as of the date of this interview but is subject to change. The information provided in this interview does not provide information reasonably sufficient upon which to base an investment decision and should not be considered a recommendation to purchase or sell any particular security. This material should not be considered an offer for any of the securities referenced. The information contained in the interview is not guaranteed as to its accuracy or completeness. Portfolio holdings are subject to change. Past performance does not guarantee future results. Equity investments are risky and subject to the volatility of the markets. The performance of any single portfolio holding is no indication of the performance of other portfolio holdings or its strategy. The intrinsic value of the investments that Project Level makes may be based on incorrect assumptions or estimations, may be affected by declining fundamentals or external forces, and may never be recognized by the broader market. This document may contain forward-looking statements relating to the objectives, opportunities, and the future performance of the markets generally. Forward looking statements may be identified by the use of such words as; "believe," "expect," "anticipate," "should," "planned," "estimated," "potential" and other similar terms. Forward-looking statements are subject to various factors, including, but not limited to general and local economic conditions, changing levels of competition within certain industries and markets, changes in interest rates, changes in legislation or regulation, and other economic, competitive, governmental, regulatory and technological factors affecting a portfolio's operations that could cause actual results to differ materially from projected results. Such statements are forward-looking in nature and involve a number of known and unknown risks, uncertainties and other factors, and accordingly, actual results may differ materially from those reflected or contemplated in such forward-looking statements. None of Project Level, Ariel Investments or any of their affiliates or principals nor any other individual or entity assumes any obligation to update any forward-looking statements as a result of new information, subsequent events or any other circumstances. All statements made herein speak only as of the date that they were made.